Rhea J Longley Selected Research

Antigens

12/2022	Acquisition of antibodies to Plasmodium falciparum and Plasmodium vivax antigens in pregnant women living in a low malaria transmission area of Brazil.
11/2022	Longitudinal IgG antibody responses to Plasmodium vivax blood-stage antigens during and after acute vivax malaria in individuals living in the Brazilian Amazon.
4/2022	Serology for Plasmodium vivax surveillance: A novel approach to accelerate towards elimination.
1/2022	Naturally acquired antibody kinetics against Plasmodium vivax antigens in people from a low malaria transmission region in western Thailand.
10/2021	SARS-CoV-2 Multi-Antigen Serology Assay.
1/2020	Preclinical Development and Assessment of Viral Vectors Expressing a Fusion Antigen of Plasmodium falciparum LSA1 and LSAP2 for Efficacy against Liver-Stage Malaria.
12/2017	An in vitro assay to measure antibody-mediated inhibition of P. berghei sporozoite invasion against P. falciparum antigens.
7/2015	Comparative assessment of vaccine vectors encoding ten malaria antigens identifies two protective liver-stage candidates.
1/2015	Development of an in vitro assay and demonstration of Plasmodium berghei liver-stage inhibition by TRAP-specific CD8+ T cells.
1/2014	Enhanced vaccine-induced CD8+ T cell responses to malaria antigen ME-TRAP by fusion to MHC class ii invariant chain.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rhea J Longley Research Topics

Disease

22	Malaria 01/2023 - 08/2012
16	Infections 09/2023 - 01/2013
3	Falciparum Malaria (Plasmodium falciparum Malaria) 12/2022 - 01/2013
2	Vivax Malaria 10/2023 - 11/2022
2	COVID-19 10/2021 - 01/2020
2	Bites and Stings (Sting) 01/2015 - 01/2013
1	Parasitic Diseases (Parasitic Disease) 04/2022
1	Asymptomatic Infections 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2013

Drug/Important Bio-Agent (IBA)

12	VaccinesIBA 11/2022 - 08/2012
11	AntigensIBA 12/2022 - 01/2013
8	Immunoglobulin G (IgG)IBA 11/2022 - 01/2016
7	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2016
6	AntibodiesIBA 12/2022 - 12/2017
3	Primaquine FDA Link 10/2023 - 01/2020
2	Malaria VaccinesIBA 01/2021 - 01/2015
2	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 01/2016 - 01/2013
1	Immunoglobulin M (IgM)IBA 06/2021
1	hemozoinIBA 01/2021
1	Chloroquine (Aralen)FDA LinkGeneric 01/2020
1	invariant chain (Ii-Key)IBA 01/2014
1	Antimalarials (Antimalarial Agents)IBA 01/2013
1	Subunit VaccinesIBA 01/2013

Therapy/Procedure

1	Aftercare (After-Treatment) 11/2016